Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Army
QuintilesIMS
Colorcon
Fuji
McKinsey
Cantor Fitzgerald
Healthtrust
Daiichi Sankyo

Generated: November 18, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Necitumumab

« Back to Dashboard

US Patents for Necitumumab

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Necitumumab ➤ Sign Up Multispecific constructs AbbVie Stemcentrx LLC (North Chicago, IL) ➤ Sign Up
Necitumumab ➤ Sign Up P97 fragments with transfer activity biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Sign Up
Necitumumab ➤ Sign Up Method for EGFR directed combination treatment of non-small cell lung cancer Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) ➤ Sign Up
Necitumumab ➤ Sign Up Meditopes and meditope-binding antibodies and uses thereof City of Hope (Duarte, CA) ➤ Sign Up
Necitumumab ➤ Sign Up Method of treatment of tumors that are resistant to EGFR antibody therapies by EGFR antibody cytotoxic agent conjugate ImmunoGen, Inc. (Waltham, MA) ➤ Sign Up
Necitumumab ➤ Sign Up Fragments of p97 and uses thereof biOasis Technologies, Inc. (Richmond, CA) ➤ Sign Up
Necitumumab ➤ Sign Up Method of target membrane protein depletion SAMSUNG ELECTRONICS CO., LTD. (Suwon-Si, KR) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Necitumumab

Drugname Country Document Number Estimated Expiration Related US Patent
Necitumumab Canada 2900764 2033-02-08 ➤ Sign Up
Necitumumab European Patent Office 2954056 2033-02-08 ➤ Sign Up
Necitumumab Hong Kong 1218930 2033-02-08 ➤ Sign Up
Necitumumab Japan 2016509014 2033-02-08 ➤ Sign Up
Necitumumab World Intellectual Property Organization (WIPO) 2014124326 2033-02-08 ➤ Sign Up
Necitumumab Australia 2012294673 2031-08-05 ➤ Sign Up
Necitumumab Canada 2842492 2031-08-05 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Argus Health
Deloitte
McKesson
Chubb
AstraZeneca
QuintilesIMS
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.